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ZIKA VIRUS: COLLECTION AND SUBMISSION 
OF FETAL TISSUES FOR ZIKA VIRUS TESTING
General Information 
The following information applies to fetal tissue collection and submission. For cord blood and amniotic fluid 
analysis, please see CDC’s web page on testing body fluid specimens.
IMPORTANT: Pre-approval is required prior to submission of any tissue specimens. 
For pre-approval please contact pathology@cdc.gov and eocevent189@cdc.gov. 
• Healthcare Providers: Please make sure that your state, territorial, tribal, or local health department has been 
notified and has received pre-approval from CDC for submission and shipment of specimens before they are 
collected and sent.  
 » Institutions with surgical pathology available: Please consult surgical pathology regarding appropriate collection 
and processing of specimens for Zika virus testing. 
 » Institutions without surgical pathology available: Please see table below for general guide on collection of 
tissue specimens for Zika virus testing. 
 » Specimens should ONLY be sent to CDC from health departments. 
• Health Departments: Pre-approval is required prior to the submission of specimens to CDC. Information required 
for the pre-approval process includes:
 » Maternal/neonatal state and specimen identification numbers, maternal age, Zika virus test results, travel locations 
and dates, illness onset (if applicable), estimated date of delivery, gestational age at delivery, pregnancy outcome, 
age and sex of infant, birth anthropometric measurements, any additional testing/imaging. 
 » Please specify cases that have been reported to the US Zika Pregnancy Registry and for which this information 
has already been provided during the pre-approval process. 
• Please Note: CDC Form 50.34 is required to be submitted with all specimens. Please write “Zika virus” in test order 
name after it is printed as this is not yet an option on the drop drown menu. 
 » Select Test Order CDC-10371 for infant deaths (pathologic evaluation of infant death due to infection)
 » Select Test Order CDC-10372 for pregnancy losses (pathologic evaluation of illness due to infection)
Collection of Fetal or Neonatal Tissues
• Appropriate consent from the parents or guardian must be obtained by the healthcare provider prior to collection and 
submission of specimens for Zika virus testing.
• To optimize evaluation of possible Zika virus infection in fetal tissues, send fixed tissues. Submission of frozen 
tissues may be considered on a case by case basis, please email pathology@cdc.gov and ZIKA_EPI_ADB@cdc.gov 
for consultation. 
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• The type of tissues available for evaluation will depend on the gestational age of the fetus and the collection 
procedure that is performed. Effort should be made to maintain the tissue architecture, and to minimize any 
dissection or disruption of the tissues.
• For situations in which individual organs or tissue types cannot be identified, please provide any available tissue with 
minimal disruption.
• CDC Infectious Diseases Pathology Branch (IDPB) accepts microscopic or gross photos from health departments 
as part of either telediagnosis consultation or routine tissue specimen submission for diagnostic evaluation. Photos 
should not contain patient names or medical record numbers. Visit the CDC ePathology telediagnosis (http://www.
cdc.gov/ncezid/dhcpp/idpb/epathology/index.html) page for more details.  
• Staff who collect and handle specimens should refer to Zika biosafety guidelines for laboratory and pathology 
procedures www.cdc.gov/zika/state-labs/biosafety-guidance.html. 
Specimen Type Fixed Specimens When to Consider General Notes
Products of conception 
(POC)
• 4 or more specimens
Generally less than 12wks 
gestational age 
For early pregnancy loss/
miscarriage, please send 
POCs fixed in formalin.
Placenta and fetal 
membranes
• Several full thickness 
pieces including at least 
3 full thickness pieces 
(0.5–1 cm x 3–4 cm in 
depth) from middle third of 
placental disk and at least 
1 from the placental disk 
margin
• One 5 x 12 cm strip of 
fetal membranes
Any gestation for which 
placenta is available
Please include sections 
of the placental disk, fetal 
membranes, and pathologic 
lesions when possible. 
Please include information 
about placenta weight and 
sample both maternal and 
fetal side of the placenta.  
Label all specimens to 
identify location of sample.
Umbilical cord
• 2.5 cm segments of cord 
• 4 or more specimens 
Any gestation for which 
placenta is available
Umbilical cord segments 
should be obtained 
proximal, middle, and distal 
to umbilical cord insertion 
site on the placenta. 
Label all specimens to 
identify location of sample.
Brain and spinal cord
• 0.5–1.0 cm3 each 
• 5 or more specimens from 
different parts of brain and 
spinal cord
Fetal demise
It is critical to maintain 
the tissue architecture to 
evaluate viral pathology. 
Certain fetal tissues require 
longer fixation, please fix 
brain specimens for 48-72 
hours.
Solid organ (heart, lung, 
liver, kidneys, skeletal 
muscle, eyes, bone 
marrow)   
• 0.5-1.0 cm3 each
• 1 representative specimen 
from each solid organ
Fetal demise 
Submission of eyes is highly 
recommended.
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Fixed Tissues 
• Histopathology, immunohistochemical staining, and reverse transcription-polymerase chain reaction (RT-PCR) 
will be performed on fixed tissues, as needed. Fixed tissues may include formalin fixed and/or paraffin embedded 
tissues.
• The volume of formalin used to fix tissues should be 10x the volume of tissue. Place tissue in 10% buffered 
formalin for a minimum of three days or until fully fixed. After fixation, tissue can be transferred to 70% ethanol for 
long term storage. 
• If stored prior to shipping, please transfer fixed tissues to 70% ethanol after 72 hours. 
• Fixed tissues should be stored and shipped at room temperature. Additional instructions for collecting, handling, 
and shipping formalin-fixed tissues are also available. Paraffin blocks should be submitted in accordance with 
these instructions for formalin-fixed specimens.
• DO NOT FREEZE samples that have been fixed in formalin. 
Submission and Shipping of Specimens 
• [CDC Form 50.34] is required with all specimen submissions and specimens should ONLY be sent to CDC directly 
from health departments. Please see introduction above for further details.
• Fixed specimens can be shipped at ambient temperature to:   
Infectious Diseases Pathology Branch 
Centers for Disease Control and Prevention 
1600 Clifton Rd. NE, MS G-32 
Atlanta GA 30329-4027
• More information on shipping can be found here: http://www.cdc.gov/ncezid/dhcpp/idpb/specimen-submission/cns.html. 
Reporting of Results
• Test results will be reported to the state health department and the submitting healthcare provider. 
• Turnaround time will vary, depending on testing volume. 
• Considerations for interpreting pathology results include maternal/infant epidemiologic risk factors, maternal/infant 
Zika testing results, and clinical presentation. For assistance with interpretation of pathology reports results please 
contact pathology@cdc.gov.   
